Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ContextLogic Inc. Reports Third-Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.comLGCB Linkage Global IncSeptember 15, 2024 | seekingalpha.comContextLogic Inc. Reports Second-Quarter Financial ResultsAugust 8, 2024 | globenewswire.comLogicBio Therapeutics, Inc. (LOGC)May 14, 2024 | finance.yahoo.comRVVTF Revive Therapeutics Ltd.March 27, 2024 | seekingalpha.comLogicBio's IPO: What You Need To KnowSeptember 24, 2023 | finance.yahoo.comRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports LtdMarch 31, 2023 | uk.finance.yahoo.comAlexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® TherapeuticsNovember 16, 2022 | finance.yahoo.comTrading was temporarily halted for "LOGC" at 07:11 PM with a stated reason of "News pending."November 16, 2022 | marketbeat.comLogicBio Therapeutics, Inc.: LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 14, 2022 | finanznachrichten.deLogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 14, 2022 | finance.yahoo.comShort Volatility Alert: LogicBio Therapeutics, Inc.November 7, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, IMRA, SBTXOctober 17, 2022 | marketwatch.comINVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGCOctober 4, 2022 | benzinga.comLooking Into LogicBio Therapeutics's Recent Short InterestOctober 3, 2022 | msn.comLogicBio Therapeutics Shares Soar on Takeover by AstraZeneca >LOGCOctober 3, 2022 | marketwatch.comAstraZeneca acquires local startup at 660% premiumOctober 3, 2022 | bizjournals.comLogicBio's stock skyrockets after buyout bid for a 667% premiumOctober 3, 2022 | finance.yahoo.comAstraZeneca pays 660% premium for gene therapy firm LogicBioOctober 3, 2022 | msn.comLogicBio To Be Bought By Alexion, AstraZeneca Rare DiseaseOctober 3, 2022 | nasdaq.comAstraZeneca to Buy LogicBio Therapeutics for $68 Million >LOGCOctober 3, 2022 | marketwatch.comWhy LogicBio Therapeutics Stock Is Soaring TodayOctober 3, 2022 | msn.comAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineOctober 3, 2022 | finance.yahoo.comLogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONESeptember 21, 2022 | finance.yahoo.comLogicBio Therapeutics IncSeptember 1, 2022 | reuters.comEarnings Update: LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported And Analysts Are Boosting Their EstimatesAugust 18, 2022 | finance.yahoo.comRecap: LogicBio Therapeutics Q2 EarningsAugust 16, 2022 | benzinga.comLogicBio Therapeutics (LOGC) Moves to Buy: Rationale Behind the UpgradeJuly 27, 2022 | finance.yahoo.comLogicBio Therapeutics Inc - Stock Quote LOGCJune 14, 2022 | morningstar.comLogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceMay 17, 2022 | finance.yahoo.comLogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business UpdatesMay 16, 2022 | finance.yahoo.comLogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual MeetingMay 11, 2022 | finance.yahoo.comWhy LogicBio Therapeutics Shares Are Popping Off TodayMay 9, 2022 | uk.investing.comLogicBio Says FDA Lifts Clinical Hold On LB-001 INDMay 9, 2022 | markets.businessinsider.comClinical Development Update from Portfolio Company LogicBioMay 9, 2022 | markets.businessinsider.comLogicBio surges as FDA lifts clinical hold on lead assetMay 9, 2022 | seekingalpha.comLogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic AcidemiaMay 9, 2022 | finance.yahoo.comLogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric TrialMay 9, 2022 | finance.yahoo.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.38%April 27, 2022 | msn.comLogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing ConferenceMarch 23, 2022 | finance.yahoo.comLogicBio Therapeutics's Return On Capital Employed InsightsMarch 12, 2022 | benzinga.comLogicBio Therapeutics to Present at Barclays Global Healthcare ConferenceMarch 8, 2022 | finance.yahoo.comLogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business UpdatesMarch 4, 2022 | finance.yahoo.comAgenus (AGEN) Reports Q4 Loss, Lags Revenue EstimatesMarch 1, 2022 | finance.yahoo.comUniQure (QURE) Tops Q4 Earnings and Revenue EstimatesFebruary 25, 2022 | finance.yahoo.comLogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical holdFebruary 3, 2022 | seekingalpha.comAnalyst Ratings For LogicBio TherapeuticsFebruary 2, 2022 | markets.businessinsider.comWhy Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?February 2, 2022 | finance.yahoo.comGene-editing company shares drop by one-third after clinical holdFebruary 2, 2022 | finance.yahoo.comArix Bioscience PLC: Clinical development update from portfolio company LogicBioFebruary 2, 2022 | finanznachrichten.de Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. LOGC Media Mentions By Week LOGC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LOGC News Sentiment▼0.000.68▲Average Retail/Wholesale News Sentiment LOGC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LOGC Articles This Week▼00▲LOGC Articles Average Week Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beyond News Kidpik News Ethan Allen Interiors News Herbalife News MarineMax News Portillo's News SpartanNash News MYT Netherlands Parent B.V. News Almacenes Éxito News Build-A-Bear Workshop News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LOGC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOGC Stock Alerts